Related Experiment Video
Updated: Apr 13, 2026

06:08
A Novel Method: Super-selective Adrenal Venous Sampling
Published on: September 15, 2017
24.1K
Single-cell transcriptomic analysis reveals metabolic reprogramming and tumor microenvironment remodeling in
Jing Huang1, Fei Qin2, Jianling Li3
1Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, China.
Genomics
|November 29, 2025
Summary
This study reveals cellular diversity in aldosterone-producing adenomas (APAs) using single-cell sequencing. It identifies metabolic reprogramming, disrupted cell differentiation, and activated signaling pathways, offering new therapeutic targets for primary aldosteronism.
Area of Science:
- Endocrinology
- Oncology
- Genomics
Background:
- Aldosterone-producing adenoma (APA) is a primary cause of primary aldosteronism.
- The cellular heterogeneity and underlying molecular mechanisms of APA remain largely uncharacterized.
Purpose of the Study:
- To comprehensively analyze the cellular landscape of APA using single-cell RNA sequencing.
- To identify key cellular pathways, biomarkers, and potential therapeutic targets in APA development.
Main Methods:
- Single-cell RNA sequencing was performed on adrenal tissues from three APA patients and three healthy controls.
- Bioinformatic analyses, including pseudotime analysis, were used to investigate cellular differentiation and pathway activation.
Main Results:
- Identification of CAPS+ zona glomerulosa (ZG)-like cells with metabolic reprogramming (lipogenesis, oxidative phosphorylation, mTOR signaling).
- Discovery of disrupted differentiation and aberrant gene expression (CYP11B1, CYP11B2, SULT2A1) in APA cells.
- Uncovering oncogenic pathway activation (Myc, Wnt), immune infiltration, angiogenic activity, and fibroblast-driven stromal remodeling (Hedgehog signaling).
Conclusions:
- This study provides a detailed single-cell atlas of APA, revealing critical tumorigenic mechanisms.
- Identified potential biomarkers (CAPS, VWF, UPK3B) and therapeutic targets (mTOR, Hedgehog/Wnt pathways) for precision medicine in adrenal tumors.
Keywords:
Aldosterone-producing adenomaCell differentiationMetabolic reprogrammingSingle-cell RNA-seqTumor microenvironment
